RecruitingNCT05606822

Endoscopic Vacuum Therapy for Transmural Defects in the Upper Gastrointestinal Tract

Endoscopic Vacuum Therapy for Anastomotic Leakage After Upper Gastrointestinal Surgery / Endoscopic Vacuum Therapy for Esophageal Perforation: A Multicenter Retrospective Cohort Study


Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

200 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the best indications and techniques regarding endoscopic vacuum therapy (EVT) in patients with a transmural defect in the upper gastrointestinal (GI) tract (e.g. anastomotic leakage, Boerhaave syndrome, iatrogenic perforation, other). The main questions it aims to answer are: * What is the success rate of EVT for transmural defects in the upper GI tract? * What are the best indications for EVT in the upper GI tract? (e.g. etiology, patient characteristics, defect characteristics) * What are the best techniques for EVT in the upper GI tract? (e.g. EsoSponge, VACStent, vacuum pressure, intraluminal/intracavitary) Participants will be asked for informed consent to retrospectively and prospectively collect data on EVT.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Treated with EVT for anastomotic leakage after esophago-gastric surgery
  • Signed informed consent form
  • years or older

Exclusion Criteria1

  • No signed informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational

Collection of data from electronic health record


Locations(1)

Amsterdam University Medical Centers, location VUmc

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05606822


Related Trials